Medicare Agency to End Some Demonstration Projects, Cancel $2 Generic Drug Initiative
The Centers for Medicare and Medicaid Services plans to terminate four demonstration projects by the end of 2025, closing out ...
Not All Generics Are Created Equal: Study Exposes a 54% Higher Risk in Indian-Made Drugs
A new study reveals that generic drugs made in India are linked to a significantly higher number of severe adverse events, ...
Key diabetes drug to cost up to 90% less in a few days
Indian drug companies are set to revolutionize diabetes treatment with affordable generic versions of Empagliflozin, ...
Rediff Money5d
Indian Generic Drugs Meet Global Standards: IPA
The Indian Pharmaceutical Alliance refutes a study claiming Indian generic drugs have higher adverse events, stating quality ...
India Trade Group Blasts Study Linking Drugs to Safety Risks
A study linking Indian-made generic drugs to a higher risk of serious side effects in the US has drawn backlash from the industry’s most influential lobby group, as India moves to defend its dominant ...
Judge Certifies Bellwether Classes in Generic Drug Litigation
A federal judge certified several classes of direct and end-payer purchasers for test trials in drug price-fixing litigation against makers of two generic drugs, clomipramine and clobetasol.
The Financial Express5d
Mankind to sell its diabetes drug, Empagliflozin, for Rs 5, company expects 50% volume growth: Rajeev Juneja
Glenmark and Alkem Labs launched the generic version as well as its Fixed Dose Combination (FDCs) of Empagliflozin in India.
Hikma looks to launch generic versions of Novo Nordisk diabetes drugs, FT says
Hikma Pharmaceuticals (HKMPF) is in talks with partners across the world to prepare to sell a generic version of Ozempic and Wegovy, as patents ...